Loading stock data...

Colinz Laboratories Limited

BSE: COLINZ

BSE
46.05 -1.45 (-3.05%)

Prev Close

47.5

Open Price

47

Volume

3,338

Today Low / High

45.2 / 47.04

52 WK Low / High

36.11 / 88.7

Range

44 - 48

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 46.05, reflecting a change of -1.45 (-3.05263%). The expected target range on the BSE is 44 - 48. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 47.00 -2.02%
24 Feb 47.50 0.00%
23 Feb 52.24 -6.78%
20 Feb 48.51 3.07%
19 Feb 50.04 1.92%
18 Feb 57.95 -9.27%
17 Feb 54.98 0.65%
16 Feb 48.18 9.57%
13 Feb 49.20 2.20%
12 Feb 51.75 -0.02%
11 Feb 57.32 -4.99%
10 Feb 57.33 -0.02%
09 Feb 63.00 -4.24%
06 Feb 61.93 2.54%
05 Feb 65.18 0.00%
04 Feb 68.62 -0.01%
03 Feb 72.22 0.00%
02 Feb 80.00 -4.98%
01 Feb 75.01 6.68%
30 Jan 84.00 -5.94%
29 Jan 77.00 3.79%
28 Jan 63.00 5.71%

Colinz Laboratories Limited Graph

Colinz Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Colinz Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 46.05, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 46.05 46.51 41.86 - 51.16
46.97 37.58 - 56.37
47.43 33.20 - 61.66
Bearish Scenario 46.05 45.59 41.03 - 50.15
45.13 36.10 - 54.15
44.67 31.27 - 58.07

Overview of Colinz Laboratories Limited

ISIN

INE923C01011

Industry

Medical - Pharmaceuticals

Vol.Avg

6,017

Market Cap

116,004,555

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

-23.94

DCF

70

Financial Ratios Every Investor Needs

Stock Rating Details for COLINZ

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 6.53 Cr 2.09 Cr 4.44 Cr 0.6798 0.01 Cr 3.01 Cr 0.36 Cr 0.50 Cr 1.97 0.50 Cr 0.0761
2024-03-31 7.03 Cr 5.43 Cr 1.60 Cr 0.2281 0.01 Cr 0.18 Cr 0.41 Cr 0.49 Cr 1.93 0.82 Cr 0.0692
2023-03-31 7.15 Cr 2.62 Cr 4.54 Cr 0.6339 0.01 Cr 0.18 Cr 0.50 Cr 0.46 Cr 1.82 0.78 Cr 0.0639
2022-03-31 6.97 Cr 2.61 Cr 4.36 Cr 0.6254 0.01 Cr 0.15 Cr 0.39 Cr 0.34 Cr 0.74 0.76 Cr 0.0487
2021-03-31 6.16 Cr 2.49 Cr 3.67 Cr 0.5965 0.02 Cr 0.11 Cr 0.14 Cr 0.21 Cr 0.45 0.52 Cr 0.0337

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.40 Cr 11.82 Cr 2.34 Cr 9.4744 Cr 0.64 Cr -4.91 Cr 0.78 Cr 1.70 Cr 0.00 Cr 0.00 Cr 1.04 Cr 2.1624 Cr
2024-03-31 2.95 Cr 11.36 Cr 2.41 Cr 8.9489 Cr 0.57 Cr -2.38 Cr 0.85 Cr 1.58 Cr 0.00 Cr 0.00 Cr 1.02 Cr 2.1815 Cr
2023-03-31 1.97 Cr 10.23 Cr 2.09 Cr 8.1392 Cr 0.27 Cr -1.69 Cr 0.94 Cr 1.71 Cr 0.75 Cr 0.00 Cr 0.66 Cr 1.8861 Cr
2022-03-31 2.09 Cr 9.93 Cr 2.24 Cr 7.6874 Cr 0.48 Cr -1.60 Cr 0.93 Cr 1.86 Cr 0.76 Cr 0.00 Cr 0.67 Cr 1.9815 Cr
2021-03-31 1.39 Cr 10.10 Cr 2.81 Cr 7.2912 Cr 0.99 Cr -0.40 Cr 1.25 Cr 2.03 Cr 0.84 Cr 0.00 Cr -2.68 Cr 2.5861 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -1.4537 Cr -0.2343 Cr 0.2380 Cr -1.7156 Cr -1.4500 Cr 5.5501 Cr -0.2619 Cr 0.4966 Cr 0.0711 Cr 0.0000 Cr 0.0660 Cr
2024-03-31 1.0348 Cr 0.0069 Cr 0.2296 Cr 1.0347 Cr 1.2712 Cr 7.0001 Cr 0.0000 Cr 0.4867 Cr 0.2964 Cr 0.0000 Cr 0.0919 Cr
2023-03-31 0.4029 Cr 0.0087 Cr 0.1111 Cr 0.4029 Cr 0.5227 Cr 5.7289 Cr 0.0000 Cr 0.5998 Cr -0.2111 Cr 0.0000 Cr -0.0135 Cr
2022-03-31 0.4671 Cr -0.0325 Cr 0.0903 Cr 0.4296 Cr 0.5249 Cr 5.2063 Cr -0.0375 Cr 0.4803 Cr -0.5081 Cr 0.0000 Cr 0.3212 Cr
2021-03-31 2.1582 Cr -0.1548 Cr 0.0801 Cr 2.0003 Cr 2.0735 Cr 4.6815 Cr -0.1579 Cr 0.2452 Cr 0.6120 Cr 0.0000 Cr 0.4446 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 1.43 Cr 1.10 Cr 0.34 Cr 0.2363 0.06 Cr 0.08 Cr 0.33 0.18 Cr 0.0583
2025-09-30 1.39 Cr 1.05 Cr 0.33 Cr 0.2402 0.04 Cr 0.14 Cr 0.56 0.24 Cr 0.1012
2025-06-30 1.57 Cr 0.40 Cr 1.17 Cr 0.7448 0.10 Cr 0.12 Cr 0.47 0.21 Cr 0.0761
2025-03-31 1.45 Cr 0.51 Cr 0.95 Cr 0.6515 0.06 Cr 0.15 Cr 0.60 0.10 Cr 0.1036
2024-12-31 1.47 Cr 0.47 Cr 1.00 Cr 0.6796 0.03 Cr 0.05 Cr 0.21 0.14 Cr 0.0363

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.82 Cr 6.60 Cr 7.42 Cr 0.77 Cr 1.02 Cr 9.23 Cr 1.62 Cr 12.13 Cr 2.25 Cr
2025-06-30 0.00 Cr 0.00 Cr 5.55 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -9.47 Cr
2025-03-31 5.55 Cr 0.00 Cr 5.55 Cr 0.66 Cr 0.78 Cr 9.02 Cr 1.70 Cr 11.82 Cr 2.34 Cr
2024-12-31 0.00 Cr 0.00 Cr 8.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -9.35 Cr
2024-09-30 3.86 Cr 4.18 Cr 8.04 Cr 0.82 Cr 0.78 Cr 9.67 Cr 1.51 Cr 12.36 Cr 3.01 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.80 ₹102,578,890,079.00 ₹242,213.00

Key Executives

Director of Legal, Corporate Affairs, Company Secretary, Compliance Officer & Director
Laxman Subu Mani

Gender: Not Specified

Year Born: 1951

Chief Executive Officer & Whole-Time Director
Narayanan Kutty Menon

Gender: male

Year Born: 1952

Chief Financial Officer
Ganesh S. Chitte

Gender: male

Year Born:

Company Secretary & Compliance Officer
Falguni Kumawat

Gender: female

Year Born:

FAQs about Colinz Laboratories Limited

Who is the CEO of the company?

The CEO is Narayanan Kutty Menon.

What is the current market price of the stock?

The current price is ₹46.05.

What is the 52-week price range?

The range is ₹36.11-88.7.

What is the market capitalization of the company?

The market capitalization is ₹11.60 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 23.50.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Colinz Laboratories Limited (ISIN: INE923C01011) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹11.60 crores and an average daily volume of 6,017 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.